Fennec Pharmaceuticals Inc. (FENC) has a market capitalization of $178.63M and trades at $6.25. The 52-week range is 4.68-9.92.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -17.4, Earnings Per Share (EPS) of $-0.36, annual revenue of $45.42M.
The stock has a beta of 0.93, operates in the Healthcare sector.
